Denali Therapeutics Inc. DNLI Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s deferred tax assets and other non-current assets?
- Denali Therapeutics Inc. (DNLI) reported deferred tax assets and other non-current assets of $26.22M in Q1 2026.
- How has Denali Therapeutics Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Denali Therapeutics Inc.'s deferred tax assets and other non-current assets decreased by 2.7% year-over-year, from $26.93M to $26.22M.
- What is the long-term trend for Denali Therapeutics Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s deferred tax assets and other non-current assets has grown at a 60.2% compound annual growth rate (CAGR), from $2.46M to $25.94M.